Semaglutide is a GLP-1 receptor agonist that may support appetite regulation, blood sugar regulation, and feelings of fullness
In the UK, commonly prescribed GLP-1 medications include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity for diabetes), and tirzepatide (Mounjaro for diabetes), which is a dual GLP-1 and GIP receptor agonist
It provides prescribing support and medication-access coordination
M., Lewis, K
Our medical team customizes Semaglutide treatments as part of a comprehensive wellness plan
The market growth is driven by the rising global prevalence of obesity, increased awareness of medical weight management solutions, and strong clinical outcomes supporting early adoption